Bank of New York Mellon’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Sell
442,675
-75,623
-15% -$2M ﹤0.01% 1811
2025
Q1
$12.5M Buy
518,298
+55,334
+12% +$1.34M ﹤0.01% 1743
2024
Q4
$18.6M Buy
462,964
+41,400
+10% +$1.67M ﹤0.01% 1607
2024
Q3
$26.7M Buy
421,564
+14,308
+4% +$906K 0.01% 1417
2024
Q2
$21.6M Buy
407,256
+58,763
+17% +$3.12M ﹤0.01% 1530
2024
Q1
$28.6M Buy
348,493
+10,785
+3% +$884K 0.01% 1373
2023
Q4
$6.28M Buy
337,708
+7,861
+2% +$146K ﹤0.01% 2251
2023
Q3
$3.65M Sell
329,847
-8,290
-2% -$91.8K ﹤0.01% 2485
2023
Q2
$5.48M Buy
338,137
+196,368
+139% +$3.18M ﹤0.01% 2275
2023
Q1
$2.36M Sell
141,769
-16,517
-10% -$275K ﹤0.01% 2708
2022
Q4
$1.49M Buy
158,286
+54,142
+52% +$509K ﹤0.01% 3000
2022
Q3
$284K Sell
104,144
-1,640
-2% -$4.47K ﹤0.01% 3863
2022
Q2
$306K Sell
105,784
-219,964
-68% -$636K ﹤0.01% 3865
2022
Q1
$977K Buy
325,748
+67,835
+26% +$203K ﹤0.01% 3332
2021
Q4
$1.19M Sell
257,913
-8,439
-3% -$38.8K ﹤0.01% 3280
2021
Q3
$1.67M Buy
266,352
+16,191
+6% +$102K ﹤0.01% 3093
2021
Q2
$1.5M Sell
250,161
-49,120
-16% -$294K ﹤0.01% 3176
2021
Q1
$1.89M Sell
299,281
-496
-0.2% -$3.14K ﹤0.01% 2951
2020
Q4
$1.69M Sell
299,777
-12,259
-4% -$69K ﹤0.01% 2942
2020
Q3
$1.82M Sell
312,036
-2,646
-0.8% -$15.4K ﹤0.01% 2720
2020
Q2
$2.27M Sell
314,682
-486
-0.2% -$3.5K ﹤0.01% 2607
2020
Q1
$1.48M Buy
315,168
+3,875
+1% +$18.1K ﹤0.01% 2712
2019
Q4
$2.5M Buy
311,293
+24,963
+9% +$200K ﹤0.01% 2685
2019
Q3
$1.97M Sell
286,330
-82,672
-22% -$569K ﹤0.01% 2763
2019
Q2
$3.06M Buy
369,002
+49,027
+15% +$407K ﹤0.01% 2574
2019
Q1
$3.18M Sell
319,975
-67,064
-17% -$667K ﹤0.01% 2547
2018
Q4
$2.96M Buy
387,039
+1,555
+0.4% +$11.9K ﹤0.01% 2546
2018
Q3
$6.71M Buy
385,484
+39,455
+11% +$687K ﹤0.01% 2256
2018
Q2
$3.28M Buy
346,029
+320,731
+1,268% +$3.04M ﹤0.01% 2591
2018
Q1
$110K Buy
+25,298
New +$110K ﹤0.01% 4034